Search results for "Treated group"

showing 5 items of 5 documents

Comparison of implant primary stability between maxillary edentulous ridges receiving intramembranous origin block grafts

2012

Purpose: The purposes of the present study were: to compare the resonance frequency analysis (RFA) values of implant placed in either ramus or calvaria block grafts; and to determine if implant diameter influences RFA implant stability quotient (ISQ) value. Material and Methods: This was a retrospective study that included 16 consecutives healthy patients treated with autogenous onlay block grafts for horizontal bone reconstruction in maxilla. Ten ramus and ten calvaria block graft treated patients were selected and compared. Results: Totally, 59 implants were placed, 35 (59.3%) were placed on the calvaria bone grafts and the remaining 24 (40.7%) were on the ramus bone graft. Of all the imp…

AdultMaleDentistryCalvariaOdontologíaYoung AdultmedicineMaxillaHumansJaw EdentulousGeneral DentistryRetrospective StudiesTreated groupBone Transplantationbusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Implant stability quotientmusculoskeletal systemCiencias de la saludResonance frequency analysismedicine.anatomical_structureOtorhinolaryngologyBone transplantationMaxillaIntramembranous ossificationUNESCO::CIENCIAS MÉDICASSurgeryFemaleResearch-ArticleImplantOral Surgerybusiness
researchProduct

Effect of trypan blue on the elasticity of the human anterior lens capsule.

2007

Purpose To evaluate the effect of trypan blue (VisionBlue) staining on the elastic properties of the human anterior lens capsule. Setting Center for Vision Science, Ruhr University Eye Hospital, Bochum, Germany. Methods Nineteen anterior capsules were obtained from 19 human eyes at the time of cataract operation. Two same-size strips were prepared from each capsule; 1 was exposed to trypan blue staining for 10 seconds, and the other was a control. The elasticity measurements were performed on both specimens using a modified rheometer. Results The mean age of the patients was 75.3 years ± 13.3 (SD) (range 35 to 89 years). Sixty-three measurements of 19 suitable specimen pairs were performed.…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentLens Capsule Crystallinechemistry.chemical_compoundOphthalmologymedicineAnterior lens capsuleHumansProspective StudiesElasticity (economics)Coloring AgentsAgedAged 80 and overTreated groupbusiness.industryCapsuleVisionBlueTrypan BlueCataract surgeryMiddle AgedSensory SystemsElasticityStainingOphthalmologychemistrySurgeryTrypan blueFemaleStress MechanicalbusinessJournal of cataract and refractive surgery
researchProduct

Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.

2015

BACKGROUND Although treatment with C1 esterase inhibitor (C1-INH) concentrate is well established for hereditary angioedema (HAE) attacks in general, data that assess its efficacy for cutaneous attack treatment are sparse. OBJECTIVE To assess efficacy of plasma-derived, nanofiltered C1-INH concentrate for cutaneous attack treatment by comparing treated attacks from the uncontrolled I.M.P.A.C.T.2 study with historical data for untreated attacks. METHODS Cutaneous attack data from patients with HAE who were treated for cutaneous edema with 20 IU/kg body weight C1-INH concentrate in the uncontrolled I.M.P.A.C.T.2 study (38 patients) were compared with data from untreated patients from an histo…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUntreated groupPeripheral edemaGastroenterologySeverity of Illness IndexYoung AdultInternal medicineSeverity of illnessmedicineImmunology and AllergyHumansYoung adultChildAgedEnd pointbusiness.industryAngioedemas HereditaryGeneral MedicineArticlesMiddle Agedmedicine.diseasePeripheralC1 esteraseTreatment OutcomeHereditary angioedemaDisease ProgressionFemalemedicine.symptombusinessComplement C1 Inhibitor ProteinAllergy and asthma proceedings
researchProduct

In vivo Antimicrobial Activity Assessment of a Cauliflower By-Product Extract Against Salmonella Typhimurium

2020

The main objective of this work was to study the antimicrobial effect of a cauliflower by-product infusion into an affordable in vivo model (Caenorhabditis elegans). The infusion demonstrated some protective effect on non-infected and infected worms with Salmonella Typhimurium as indicated by higher survival percentile values (75, 50, 25, and 5% percentiles) as compared with those from worms unexposed to the infusion. The antimicrobial effect of the infusion was evaluated on Salmonella intestinal colonization of infected worms (24, 48, and 96 h post-infection). At 96 h post-infection, the concentration of Salmonella was reduced around 2 log cycles in infected cauliflower treated group (p < …

Salmonella typhimuriumSalmonellaActivity assessmentBy-productlcsh:TX341-641Antimicrobial activityHorticultureManagement Monitoring Policy and Lawmedicine.disease_causeMicrobiologyCauliflowersIn vivoAntimicrobial effectby-productBy-productmedicineTreated groupGlobal and Planetary Changeantimicrobial activitybiologylcsh:TP368-456Ecologycaulifloweragro-industrial wasteAgro-industrial wastebiology.organism_classificationAntimicrobiallcsh:Food processing and manufactureNematodeSalmonella TyphimuriumC. eleganslcsh:Nutrition. Foods and food supplyAgronomy and Crop ScienceFood ScienceFrontiers in Sustainable Food Systems
researchProduct

Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness

2018

Abstract Objective To confirm the clinical security and effectiveness of the daily application of 0.01% superdiluted atropine eyedrops in the progression of myopia in children. Material and methods A total of 200 children 9–12 years of age were randomized into a treated group and a control without treatment. Refraction under cycloplegia was performed. Results Myopia progression of the treated group was −0.14 ± 0.35 versus −0.65 ± 0.54 in the control group without treatment. Only 2% of patients were forced to stop treatment due to side effects. Conclusion Atropine superdiluted atropine 0.01% eyedrops is effective and well tolerated, and reduced myopia progression by 25%.

Treated groupgenetic structuresbusiness.industryCycloplegiaGeneral Medicine03 medical and health sciencesAtropine0302 clinical medicineAnesthesia030221 ophthalmology & optometrymedicinemedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct